北京體育文化(01803.HK):終止向中互海州(深圳)商業設施注資
格隆匯 8 月 20日丨北京體育文化(01803.HK)發佈公告,有關向中互海州(深圳)商業設施有限公司注資。誠如此前公告所載,深圳市艾斯諾、劉先生、北體睿晟及周先生訂立協議,據此,北體睿晟將向目標公司注資人民幣6375萬元,注資完成後,北體睿晟將擁有目標公司經擴大股權的51%。
集團獲告知,深圳市艾斯諾未能達成此前公告所述的先決條件(iv)。儘管其後協議的訂約方進一步進行討論,惟並無達成進一步協議,故此,根據有關訂約方訂立日期為2018年6月19日的終止協議,協議的訂約方已終止協議,協議項下訂約各方的權利及義務將告終止,且不得向另一方提出申索。因此,注資並無進行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.